GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Cyclically Adjusted Revenue per Share

Charmacy Pharmaceutical Co (HKSE:02289) Cyclically Adjusted Revenue per Share : HK$46.19 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Charmacy Pharmaceutical Co's adjusted revenue per share data for the fiscal year that ended in Dec. 2023 was HK$44.597. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is HK$46.19 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-09), Charmacy Pharmaceutical Co's current stock price is HK$ 8.60. Charmacy Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec. 2023 was HK$46.19. Charmacy Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 0.19.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Charmacy Pharmaceutical Co was 0.31. The lowest was 0.19. And the median was 0.24.


Charmacy Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Charmacy Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 46.19

Charmacy Pharmaceutical Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 46.19

Competitive Comparison of Charmacy Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charmacy Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Charmacy Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Charmacy Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Charmacy Pharmaceutical Co's adjusted Revenue per Share data for the fiscal year that ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=44.597/114.7809*114.7809
=44.597

Current CPI (Dec. 2023) = 114.7809.

Charmacy Pharmaceutical Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 47.206 99.000 54.731
201512 50.027 100.600 57.079
201612 38.101 102.600 42.624
201712 44.935 104.500 49.356
201812 41.393 106.500 44.612
201912 35.988 111.200 37.147
202012 43.812 111.500 45.101
202112 43.015 113.108 43.651
202212 43.172 115.116 43.046
202312 44.597 114.781 44.597

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Charmacy Pharmaceutical Co  (HKSE:02289) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Charmacy Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=8.60/46.19
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Charmacy Pharmaceutical Co was 0.31. The lowest was 0.19. And the median was 0.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Charmacy Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Charmacy Pharmaceutical Co (HKSE:02289) Business Description

Traded in Other Exchanges
N/A
Address
No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041
Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes diversified pharmaceutical products to pharmaceutical distributors, retail pharmacies, hospitals, clinics, and health centers. The company's distribution network covers Southern China and surrounding areas including Fujian province. The firm offers Western medicines, Chinese patent medicines, healthcare products, Chinese medicine material and decoction pieces, medical devices, cosmetic products, and others. All the group's operations are located in China.
Executives
Jiangxi Pharmaceutical Investment Co., Limited 2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Yao Chuanglong 2101 Beneficial owner
You Zeyan 2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si 2101 Beneficial owner
Rays Capital Partners Limited 2102 Investment manager
Ruan David Ching Chi 2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited 2101 Beneficial owner
Wang Yonghui 2101 Beneficial owner

Charmacy Pharmaceutical Co (HKSE:02289) Headlines

No Headlines